Ugur Acar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ugur Acar has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Damla Erginturk Acar
Minister Hlth Ankara City Hosp, TR-06800 Ankara, Turkey
7 shared publications- Damla Erginturk Acar
Division of Ophthalmology, Ministry of Health, Kastamonu Dr. Münif İslamoğlu National Hospital, Kastamonu, Turkey
6 shared publications Ozdemir Ozdemir
Department of Ophthalmology, Zekai Tahir Burak Women's Health Training and Research Hospital, Ankara, Turkey
5 shared publications- Zuhal Ozen Tunay
TOBB University of Economics and Technology Faculty of Medicine, Department of Ophthalmology, Ankara, Türkiye
4 shared publications Emrullah Beyazyildiz
Department of Ophthalmology, Samsun Training and Research Hospital, Samsun, Turkey
3 shared publicationsGungor Sobaci
Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Kazakistan Caddesi 90/7 Emek-Ankara, Ankara, Turkey
3 shared publications
Latest Publications
- 9 April 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 199
Evaluation of the triglyceride-glucose index, serum inflammatory biomarkers and lipid profile in patients with neovascular age-related macular degeneration
Purpose To evaluate the triglyceride–glucose index (TyG), novel systemic inflammatory biomarkers, and lipid profile in patients with neovascular age-related macular degeneration (nAMD), and to investigate their potential relationship with disease presence. Methods This retrospective case–control study included 59 patients diagnosed with nAMD and 67 age- and sex-matched healthy controls. Demographic characteristics, fasting biochemical tests, lipid profile, complete blood count, and serum inflammatory indices were recorded. Triglyceride–glucose index, systemic inflammatory indices derived from various hematological parameters and lipid levels were calculated. Laboratory parameters and calculated indexes were compared between the two groups using Statistical Package for the Social Sciences (SPSS). Results Triglyceride–glucose index was significantly higher in the nAMD group than in controls (4.84 ± 0.27 vs. 4.69 ± 0.17, p = 0.0001). Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels were also elevated in the nAMD group (p = 0.0001 for both). Among hematological markers, white blood count (WBC), neutrophil, and monocyte counts were significantly increased in nAMD patients (p = 0.012, p = 0.001, p = 0.015, respectively). Inflammatory indices including neutrophil/lymphocyte ratio (NLR) (p = 0.015), monocyte/HDL-C ratio (MHR) (p = 0.003), systemic inflammation aggregate index (AISI) (p = 0.025), and C reactive protein/albumine ratio (CAR) (p = 0.006) were significantly higher in the nAMD group, whereas the systemic immune inflammation index (SII), platelet/lymphocyte ratio (PLR) and monocyte/lymphocyte ratio (MLR) showed no significant differences (p > 0.05). Serum lipid levels and atherogenic lipid ratios did not differ between the groups. Discussion Patients with nAMD exhibit increased systemic inflammatory activity and metabolic stress, reflected by elevated NLR, MHR, AISI, and CAR levels. In addition, TyG, a novel indicator of systemic insulin resistance, was found to be elevated in nAMD patients. These findings suggest that metabolic dysregulation and chronic low-grade systemic inflammation may contribute to nAMD pathogenesis independently of serum lipid levels. The TyG and inflammation-derived biomarkers may serve as potential systemic indicators for nAMD risk or disease activity.
- 9 April 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 199
Evaluation of the triglyceride-glucose index, serum inflammatory biomarkers and lipid profile in patients with neovascular age-related macular degeneration
Purpose To evaluate the triglyceride–glucose index (TyG), novel systemic inflammatory biomarkers, and lipid profile in patients with neovascular age-related macular degeneration (nAMD), and to investigate their potential relationship with disease presence. Methods This retrospective case–control study included 59 patients diagnosed with nAMD and 67 age- and sex-matched healthy controls. Demographic characteristics, fasting biochemical tests, lipid profile, complete blood count, and serum inflammatory indices were recorded. Triglyceride–glucose index, systemic inflammatory indices derived from various hematological parameters and lipid levels were calculated. Laboratory parameters and calculated indexes were compared between the two groups using Statistical Package for the Social Sciences (SPSS). Results Triglyceride–glucose index was significantly higher in the nAMD group than in controls (4.84 ± 0.27 vs. 4.69 ± 0.17, p = 0.0001). Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels were also elevated in the nAMD group (p = 0.0001 for both). Among hematological markers, white blood count (WBC), neutrophil, and monocyte counts were significantly increased in nAMD patients (p = 0.012, p = 0.001, p = 0.015, respectively). Inflammatory indices including neutrophil/lymphocyte ratio (NLR) (p = 0.015), monocyte/HDL-C ratio (MHR) (p = 0.003), systemic inflammation aggregate index (AISI) (p = 0.025), and C reactive protein/albumine ratio (CAR) (p = 0.006) were significantly higher in the nAMD group, whereas the systemic immune inflammation index (SII), platelet/lymphocyte ratio (PLR) and monocyte/lymphocyte ratio (MLR) showed no significant differences (p > 0.05). Serum lipid levels and atherogenic lipid ratios did not differ between the groups. Discussion Patients with nAMD exhibit increased systemic inflammatory activity and metabolic stress, reflected by elevated NLR, MHR, AISI, and CAR levels. In addition, TyG, a novel indicator of systemic insulin resistance, was found to be elevated in nAMD patients. These findings suggest that metabolic dysregulation and chronic low-grade systemic inflammation may contribute to nAMD pathogenesis independently of serum lipid levels. The TyG and inflammation-derived biomarkers may serve as potential systemic indicators for nAMD risk or disease activity.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 741-746
Outcomes of transcorneal electrical stimulation treatmentin the early stages of retinitis pigmentosa
By MUHAMMED NECATİ DEMİR, UĞUR ACAR, GÜNGÖR SOBACI, et al., Published on 01/01/22
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 741-746
Open AccessOutcomes of transcorneal electrical stimulation treatmentin the early stages of retinitis pigmentosa
By MUHAMMED NECATİ DEMİR, UĞUR ACAR, GÜNGÖR SOBACI, et al., Published on 01/01/22
- 18 February 2021
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 14 (2) , 277-282
Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity
AIM: To investigate the effects of diode laser treatment on ocular biometric parameters in premature infants with retinopathy of prematurity (ROP). METHODS: Premature infants who received diode laser treatment for ROP (n=68) and premature infants with spontaneous regressed ROP without treatment (n=50) were performed longitudinal ocular biometric measurements including anterior chamber depth, lens thickness and axial length as follows: 1d prior to laser treatment, and 3, 6, 9, and 12mo after the laser treatment. RESULTS: The mean birth weight, gestational age and initial examination time values were 936.53±302.07 g, 26.66±2.42wk, 36.26±2.73wk in the treatment group and 959.78±260.08 g, 27.28±2.10wk, 36.56±2.54wk in the control group. There was no statistically significant difference in these demographic characteristics of the groups. Anterior chamber depth, lens thickness and axial length demonstrated statistically significant linear increases during the study period in the two groups (P<0.001 for each). There were no statistically significant differences between the two groups in terms of anterior chamber depth after laser treatment. Measurements of the lens thickness at 9th and 12th months (9th month 3.70±0.22 vs 3.60±0.21 mm, P=0.017; 12th month 3.81±0.21 vs 3.69±0.22 mm, P=0.002) and the axial length at 12th month (19.35±0.79 vs 19.13±0.54 mm, P=0.031) after laser treatment were statistically higher in the treatment group. CONCLUSION: Diode laser retinal photocoagulation treatment in premature infants seems to increase the lens thickness and axial length.
- 18 February 2021
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 14 (2) , 277-282
Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity
AIM: To investigate the effects of diode laser treatment on ocular biometric parameters in premature infants with retinopathy of prematurity (ROP). METHODS: Premature infants who received diode laser treatment for ROP (n=68) and premature infants with spontaneous regressed ROP without treatment (n=50) were performed longitudinal ocular biometric measurements including anterior chamber depth, lens thickness and axial length as follows: 1d prior to laser treatment, and 3, 6, 9, and 12mo after the laser treatment. RESULTS: The mean birth weight, gestational age and initial examination time values were 936.53±302.07 g, 26.66±2.42wk, 36.26±2.73wk in the treatment group and 959.78±260.08 g, 27.28±2.10wk, 36.56±2.54wk in the control group. There was no statistically significant difference in these demographic characteristics of the groups. Anterior chamber depth, lens thickness and axial length demonstrated statistically significant linear increases during the study period in the two groups (P<0.001 for each). There were no statistically significant differences between the two groups in terms of anterior chamber depth after laser treatment. Measurements of the lens thickness at 9th and 12th months (9th month 3.70±0.22 vs 3.60±0.21 mm, P=0.017; 12th month 3.81±0.21 vs 3.69±0.22 mm, P=0.002) and the axial length at 12th month (19.35±0.79 vs 19.13±0.54 mm, P=0.031) after laser treatment were statistically higher in the treatment group. CONCLUSION: Diode laser retinal photocoagulation treatment in premature infants seems to increase the lens thickness and axial length.
- 2 January 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 41 (3) , 1071-1079
Retinal choroidal and retinal nerve fiber layer thickness in former preterm and full-term infants aged 4 to 8 years
Purpose To compare the retinal thickness at the fovea center, peripapillary retinal nerve fiber layer (RNFL) thickness and choroidal thickness (CT) in former preterm and full-term infants. Methods A total of 121 healthy children aged 4–8 years were divided 4 groups: group 1; children born on time, group 2; preterm children without a history of retinopathy of prematurity (ROP), group 3; preterm children with a history of spontaneously regressed ROP and group 4; preterm children who underwent diode laser photocoagulation for ROP. The retinal thickness at the fovea, peripapillary RNFL thickness at global, superior, inferior, nasal and temporal quadrants and submacular CT at 7 different points were measured by using spectral-domain optical coherence tomography. Results The mean retinal thickness at the fovea center was statistically higher, whereas the mean RNFL thickness values in global, nasal, superior and inferior quadrants were statistically lower in group 4. No difference was found in the mean submacular CT value of any point between the groups. Conclusion Transpupillary diode laser photocoagulation treatment for ROP seems to cause an increase in macular thickness and a decrease in RNFL thickness.
- 2 January 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 41 (3) , 1071-1079
Retinal choroidal and retinal nerve fiber layer thickness in former preterm and full-term infants aged 4 to 8 years
Purpose To compare the retinal thickness at the fovea center, peripapillary retinal nerve fiber layer (RNFL) thickness and choroidal thickness (CT) in former preterm and full-term infants. Methods A total of 121 healthy children aged 4–8 years were divided 4 groups: group 1; children born on time, group 2; preterm children without a history of retinopathy of prematurity (ROP), group 3; preterm children with a history of spontaneously regressed ROP and group 4; preterm children who underwent diode laser photocoagulation for ROP. The retinal thickness at the fovea, peripapillary RNFL thickness at global, superior, inferior, nasal and temporal quadrants and submacular CT at 7 different points were measured by using spectral-domain optical coherence tomography. Results The mean retinal thickness at the fovea center was statistically higher, whereas the mean RNFL thickness values in global, nasal, superior and inferior quadrants were statistically lower in group 4. No difference was found in the mean submacular CT value of any point between the groups. Conclusion Transpupillary diode laser photocoagulation treatment for ROP seems to cause an increase in macular thickness and a decrease in RNFL thickness.
- Open Access
- 1 January 2020
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 5 (3) , 238-241
Amniotic Membrane Transplantation For Spontaneous Corneal Perforation in a case of Rheumatoid Arthritis
This report describes a case of spontaneous corneal perforation in a patient with rheumatoid arthritis (RA) and highlights the efficacy of treatment with amniotic membrane transplantation (AMT). A 58-year-old African-American woman with RA presented with complaints of redness and blurred vision in the right eye. Spontaneous corneal perforation and iris prolapse were determined in the paracentral corneal region of the right eye. Two-layer AMT surgery was performed. The anterior chamber began to improve 2 weeks after the AMT. Treatment for RA was scheduled with the rheumatology department.
- 1 January 2020
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 5 (3) , 238-241
Open AccessAmniotic Membrane Transplantation For Spontaneous Corneal Perforation in a case of Rheumatoid Arthritis
This report describes a case of spontaneous corneal perforation in a patient with rheumatoid arthritis (RA) and highlights the efficacy of treatment with amniotic membrane transplantation (AMT). A 58-year-old African-American woman with RA presented with complaints of redness and blurred vision in the right eye. Spontaneous corneal perforation and iris prolapse were determined in the paracentral corneal region of the right eye. Two-layer AMT surgery was performed. The anterior chamber began to improve 2 weeks after the AMT. Treatment for RA was scheduled with the rheumatology department.
- 19 May 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (3) , 1021-1025
Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human
To evaluate the whether intravitreal erythropoietin (EPO) administration has any beneficial or adverse effect in patients with late-stage optic neuropathy (ON) or not.
- 19 May 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (3) , 1021-1025
Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human
To evaluate the whether intravitreal erythropoietin (EPO) administration has any beneficial or adverse effect in patients with late-stage optic neuropathy (ON) or not.
- Open Access
- 28 December 2016
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 51 (1) , 11-19
Ocular Injuries In Sport
Spor ile ilişkili göz yaralanmaları önemli morbidite, körlük ve iş gücü kaybı nedenlerinden biridir. Özellikle çocuklar ve boyatopu (paintball), basketbol ve buz hokeyi sporu gibi bazı sporlarla ilgilenenler yüksek risk altındadır. Spor dalları bu yaralanma risklerine göre yüksek risk, orta risk, düşük risk olarak sınıflandırılabilir. Gözle ilgili travmanın boyutu, göze gelen cismin şekli, hızı ve sertliğine bağlıdır. Hekim dikkatli bir öykü ve fizik muayene ile yaralanmanın ciddiyeti hakkında fikir sahibi olabilir. Bu kapsamda spor hekimi yaralanmaya ilk müdahaleyi yapabilmeli, hangi tür yaralanmaları göz uzmanına yönlendirmesi gerektiğini ve hangi tür yaralanmalarda oyuna devam etmeme kararı alması gerektiğini bilmelidir. Spor ile ilişkili göz yaralanmalarının en önemli özelliği %90'ının önlenebilir nitelikte olmasıdır. Koruyucu gözlüklerin kullanımı ve alınacak basit önlemler oyuncuyu ciddi yaralanmalardan önemli ölçüde korumaktadır.
- 28 December 2016
- Published by Turkish Journal of Sports Medicine, Turkish Sports Medicine Association in Turkish Journal of Sports Medicine
- Vol. 51 (1) , 11-19
Open AccessOcular Injuries In Sport
Spor ile ilişkili göz yaralanmaları önemli morbidite, körlük ve iş gücü kaybı nedenlerinden biridir. Özellikle çocuklar ve boyatopu (paintball), basketbol ve buz hokeyi sporu gibi bazı sporlarla ilgilenenler yüksek risk altındadır. Spor dalları bu yaralanma risklerine göre yüksek risk, orta risk, düşük risk olarak sınıflandırılabilir. Gözle ilgili travmanın boyutu, göze gelen cismin şekli, hızı ve sertliğine bağlıdır. Hekim dikkatli bir öykü ve fizik muayene ile yaralanmanın ciddiyeti hakkında fikir sahibi olabilir. Bu kapsamda spor hekimi yaralanmaya ilk müdahaleyi yapabilmeli, hangi tür yaralanmaları göz uzmanına yönlendirmesi gerektiğini ve hangi tür yaralanmalarda oyuna devam etmeme kararı alması gerektiğini bilmelidir. Spor ile ilişkili göz yaralanmalarının en önemli özelliği %90'ının önlenebilir nitelikte olmasıdır. Koruyucu gözlüklerin kullanımı ve alınacak basit önlemler oyuncuyu ciddi yaralanmalardan önemli ölçüde korumaktadır.
- 1 December 2016
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 20 (6) , 553
Traumatic open globe injury in young pediatric patients: characterization of a novel prognostic score
- 1 December 2016
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 20 (6) , 553
Traumatic open globe injury in young pediatric patients: characterization of a novel prognostic score
- 19 March 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 44 (7) , 587-596
Effects of commonly used intravitreal anti‐vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body
Background: To investigate the effects of commonly used intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) antibodies on proliferation index and viability of mesenchymal stem cells derived from ciliary body and limbus (CB‐MSC and LMSC).Methods: CB‐MSCs and LMSCs were isolated from newborn rats' eyes, and they were expanded in medium by the explant method. Intravitreally used anti‐VEGF drugs, aflibercept, bevacizumab and ranibizumab were tested into the 16‐well plates, respectively, at four different concentrations. After keeping them for 48 h, the proliferation indexes and viabilities of CB‐MSCs and LMSCs were compared separately by Real‐Time Cell Analyzer and Methylthiazoltetrazoli (MTT) test.Results: Anti‐VEGFs used at 5‐times and 10‐times of the standard clinical dosage caused statistically significant negative effects on proliferation indexes of CB‐MSCs and LMSCs at the 24th hour compared to control group. Only the anti‐VEGF group that had 10‐times dosage of those used clinically had a statistically significant negative effect on the viabilties of CB‐MSCs and LMSCs.Conclusion: Administrations of high doses or repeated standard doses of intravitreal anti‐VEGF agents may affect the proliferation indexes and viabilities of CB‐MSCs and LMSCs adversely. These novel findings deserve further in vivo investigations.
- 19 March 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 44 (7) , 587-596
Effects of commonly used intravitreal anti‐vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body
Background: To investigate the effects of commonly used intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) antibodies on proliferation index and viability of mesenchymal stem cells derived from ciliary body and limbus (CB‐MSC and LMSC).Methods: CB‐MSCs and LMSCs were isolated from newborn rats' eyes, and they were expanded in medium by the explant method. Intravitreally used anti‐VEGF drugs, aflibercept, bevacizumab and ranibizumab were tested into the 16‐well plates, respectively, at four different concentrations. After keeping them for 48 h, the proliferation indexes and viabilities of CB‐MSCs and LMSCs were compared separately by Real‐Time Cell Analyzer and Methylthiazoltetrazoli (MTT) test.Results: Anti‐VEGFs used at 5‐times and 10‐times of the standard clinical dosage caused statistically significant negative effects on proliferation indexes of CB‐MSCs and LMSCs at the 24th hour compared to control group. Only the anti‐VEGF group that had 10‐times dosage of those used clinically had a statistically significant negative effect on the viabilties of CB‐MSCs and LMSCs.Conclusion: Administrations of high doses or repeated standard doses of intravitreal anti‐VEGF agents may affect the proliferation indexes and viabilities of CB‐MSCs and LMSCs adversely. These novel findings deserve further in vivo investigations.